Delayed False Elevation of Circulating Tacrolimus Concentrations after Cord Blood Transplantation in a Patient with Myelodysplastic Syndrome

We herein describe the case of a 60-year-old man with a history of Behçet's disease and myelodysplastic syndrome who received cord blood transplantation (CBT). The patient was given anti-thymocyte globulin conditioning and tacrolimus to prevent graft-versus-host disease. Two months after CBT, h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Internal Medicine 2014, Vol.53(22), pp.2635-2638
Hauptverfasser: Hayashi, Kiyohito, Tasaka, Taizo, Hirose, Tadashi, Furukawa, Satoko, Kohguchi, Katsunori, Matsuhashi, Yoshiko, Wada, Hideho, Tohyama, Kaoru, Sugihara, Takashi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2638
container_issue 22
container_start_page 2635
container_title Internal Medicine
container_volume 53
creator Hayashi, Kiyohito
Tasaka, Taizo
Hirose, Tadashi
Furukawa, Satoko
Kohguchi, Katsunori
Matsuhashi, Yoshiko
Wada, Hideho
Tohyama, Kaoru
Sugihara, Takashi
description We herein describe the case of a 60-year-old man with a history of Behçet's disease and myelodysplastic syndrome who received cord blood transplantation (CBT). The patient was given anti-thymocyte globulin conditioning and tacrolimus to prevent graft-versus-host disease. Two months after CBT, his blood Tac concentration measured by an antibody-conjugated magnetic immunoassay (ACMIA) was found to have increased >4-fold, even after the Tac treatment was stopped. This false response was caused by the interference of endogenous heterophilic antibodies with ACMIA. Therefore, physicians must be aware of possible false ACMIA results for patients with a history of autoimmune disease and/or treated by xenogeneic antibody therapy.
doi_str_mv 10.2169/internalmedicine.53.2170
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1794501347</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1794501347</sourcerecordid><originalsourceid>FETCH-LOGICAL-c560t-68e6d40c96f7746bb4606adf2b5dfb66b16ad07efc9d4c29ea940ce0116f1f093</originalsourceid><addsrcrecordid>eNqFkc1u1DAQxy0EokvhFZCPXNLaiePER1hailRUJJZz5Njj1pVjL7YDyjvw0DjssgeExGXsmfnNh-aPEKbkoqZcXFqfIXrpJtBWWQ8XbVMSHXmCNrRhourqpn2KNkTQvqqLOUMvUnokpOk7UT9HZ3XLCKG92KCf78HJBTS-li4BvnLwXWYbPA4Gb21Usyuuv8c7qWJwdpoT3gavwOf4m0tYmrJLCUaN37kQNN5F6dPeSZ8PnazHEn8u_1KEf9j8gD8t4IJeVihlq_CXxesYJniJnpl1jVfH9xx9vb7abW-q27sPH7dvbyvVcpIr3gPXjCjBTdcxPo6MEy61qcdWm5HzkRaPdGCU0EzVAqQoNBBKuaGGiOYcvTn03cfwbYaUh8kmBa7sDGFOA-0Ea0m5ZPd_lDeMiZ40vKD9AS2XSimCGfbRTjIuAyXDKtvwt2xD2wyrbKX09XHKPJbkqfCPTgW4OwCPKct7OAEylvs5-HfnerXHESdSPcg4gG9-AcBuuYY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1634498036</pqid></control><display><type>article</type><title>Delayed False Elevation of Circulating Tacrolimus Concentrations after Cord Blood Transplantation in a Patient with Myelodysplastic Syndrome</title><source>MEDLINE</source><source>J-STAGE (Japan Science &amp; Technology Information Aggregator, Electronic) Freely Available Titles - Japanese</source><creator>Hayashi, Kiyohito ; Tasaka, Taizo ; Hirose, Tadashi ; Furukawa, Satoko ; Kohguchi, Katsunori ; Matsuhashi, Yoshiko ; Wada, Hideho ; Tohyama, Kaoru ; Sugihara, Takashi</creator><creatorcontrib>Hayashi, Kiyohito ; Tasaka, Taizo ; Hirose, Tadashi ; Furukawa, Satoko ; Kohguchi, Katsunori ; Matsuhashi, Yoshiko ; Wada, Hideho ; Tohyama, Kaoru ; Sugihara, Takashi</creatorcontrib><description>We herein describe the case of a 60-year-old man with a history of Behçet's disease and myelodysplastic syndrome who received cord blood transplantation (CBT). The patient was given anti-thymocyte globulin conditioning and tacrolimus to prevent graft-versus-host disease. Two months after CBT, his blood Tac concentration measured by an antibody-conjugated magnetic immunoassay (ACMIA) was found to have increased &gt;4-fold, even after the Tac treatment was stopped. This false response was caused by the interference of endogenous heterophilic antibodies with ACMIA. Therefore, physicians must be aware of possible false ACMIA results for patients with a history of autoimmune disease and/or treated by xenogeneic antibody therapy.</description><identifier>ISSN: 0918-2918</identifier><identifier>EISSN: 1349-7235</identifier><identifier>DOI: 10.2169/internalmedicine.53.2170</identifier><identifier>PMID: 25400189</identifier><language>eng</language><publisher>Japan: The Japanese Society of Internal Medicine</publisher><subject>antibody-conjugated magnetic immunoassay ; autoimmune diseases ; Behcet Syndrome - epidemiology ; Cord Blood Stem Cell Transplantation ; cord blood transplantation ; Cyclosporine - administration &amp; dosage ; False Positive Reactions ; Graft vs Host Disease - prevention &amp; control ; Humans ; Immunoassay ; Immunosuppressive Agents - administration &amp; dosage ; Male ; Middle Aged ; Myelodysplastic Syndromes - epidemiology ; Myelodysplastic Syndromes - therapy ; tacrolimus ; Tacrolimus - administration &amp; dosage</subject><ispartof>Internal Medicine, 2014, Vol.53(22), pp.2635-2638</ispartof><rights>2014 by The Japanese Society of Internal Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c560t-68e6d40c96f7746bb4606adf2b5dfb66b16ad07efc9d4c29ea940ce0116f1f093</citedby><cites>FETCH-LOGICAL-c560t-68e6d40c96f7746bb4606adf2b5dfb66b16ad07efc9d4c29ea940ce0116f1f093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25400189$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hayashi, Kiyohito</creatorcontrib><creatorcontrib>Tasaka, Taizo</creatorcontrib><creatorcontrib>Hirose, Tadashi</creatorcontrib><creatorcontrib>Furukawa, Satoko</creatorcontrib><creatorcontrib>Kohguchi, Katsunori</creatorcontrib><creatorcontrib>Matsuhashi, Yoshiko</creatorcontrib><creatorcontrib>Wada, Hideho</creatorcontrib><creatorcontrib>Tohyama, Kaoru</creatorcontrib><creatorcontrib>Sugihara, Takashi</creatorcontrib><title>Delayed False Elevation of Circulating Tacrolimus Concentrations after Cord Blood Transplantation in a Patient with Myelodysplastic Syndrome</title><title>Internal Medicine</title><addtitle>Intern. Med.</addtitle><description>We herein describe the case of a 60-year-old man with a history of Behçet's disease and myelodysplastic syndrome who received cord blood transplantation (CBT). The patient was given anti-thymocyte globulin conditioning and tacrolimus to prevent graft-versus-host disease. Two months after CBT, his blood Tac concentration measured by an antibody-conjugated magnetic immunoassay (ACMIA) was found to have increased &gt;4-fold, even after the Tac treatment was stopped. This false response was caused by the interference of endogenous heterophilic antibodies with ACMIA. Therefore, physicians must be aware of possible false ACMIA results for patients with a history of autoimmune disease and/or treated by xenogeneic antibody therapy.</description><subject>antibody-conjugated magnetic immunoassay</subject><subject>autoimmune diseases</subject><subject>Behcet Syndrome - epidemiology</subject><subject>Cord Blood Stem Cell Transplantation</subject><subject>cord blood transplantation</subject><subject>Cyclosporine - administration &amp; dosage</subject><subject>False Positive Reactions</subject><subject>Graft vs Host Disease - prevention &amp; control</subject><subject>Humans</subject><subject>Immunoassay</subject><subject>Immunosuppressive Agents - administration &amp; dosage</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myelodysplastic Syndromes - epidemiology</subject><subject>Myelodysplastic Syndromes - therapy</subject><subject>tacrolimus</subject><subject>Tacrolimus - administration &amp; dosage</subject><issn>0918-2918</issn><issn>1349-7235</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1DAQxy0EokvhFZCPXNLaiePER1hailRUJJZz5Njj1pVjL7YDyjvw0DjssgeExGXsmfnNh-aPEKbkoqZcXFqfIXrpJtBWWQ8XbVMSHXmCNrRhourqpn2KNkTQvqqLOUMvUnokpOk7UT9HZ3XLCKG92KCf78HJBTS-li4BvnLwXWYbPA4Gb21Usyuuv8c7qWJwdpoT3gavwOf4m0tYmrJLCUaN37kQNN5F6dPeSZ8PnazHEn8u_1KEf9j8gD8t4IJeVihlq_CXxesYJniJnpl1jVfH9xx9vb7abW-q27sPH7dvbyvVcpIr3gPXjCjBTdcxPo6MEy61qcdWm5HzkRaPdGCU0EzVAqQoNBBKuaGGiOYcvTn03cfwbYaUh8kmBa7sDGFOA-0Ea0m5ZPd_lDeMiZ40vKD9AS2XSimCGfbRTjIuAyXDKtvwt2xD2wyrbKX09XHKPJbkqfCPTgW4OwCPKct7OAEylvs5-HfnerXHESdSPcg4gG9-AcBuuYY</recordid><startdate>20140101</startdate><enddate>20140101</enddate><creator>Hayashi, Kiyohito</creator><creator>Tasaka, Taizo</creator><creator>Hirose, Tadashi</creator><creator>Furukawa, Satoko</creator><creator>Kohguchi, Katsunori</creator><creator>Matsuhashi, Yoshiko</creator><creator>Wada, Hideho</creator><creator>Tohyama, Kaoru</creator><creator>Sugihara, Takashi</creator><general>The Japanese Society of Internal Medicine</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20140101</creationdate><title>Delayed False Elevation of Circulating Tacrolimus Concentrations after Cord Blood Transplantation in a Patient with Myelodysplastic Syndrome</title><author>Hayashi, Kiyohito ; Tasaka, Taizo ; Hirose, Tadashi ; Furukawa, Satoko ; Kohguchi, Katsunori ; Matsuhashi, Yoshiko ; Wada, Hideho ; Tohyama, Kaoru ; Sugihara, Takashi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c560t-68e6d40c96f7746bb4606adf2b5dfb66b16ad07efc9d4c29ea940ce0116f1f093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>antibody-conjugated magnetic immunoassay</topic><topic>autoimmune diseases</topic><topic>Behcet Syndrome - epidemiology</topic><topic>Cord Blood Stem Cell Transplantation</topic><topic>cord blood transplantation</topic><topic>Cyclosporine - administration &amp; dosage</topic><topic>False Positive Reactions</topic><topic>Graft vs Host Disease - prevention &amp; control</topic><topic>Humans</topic><topic>Immunoassay</topic><topic>Immunosuppressive Agents - administration &amp; dosage</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myelodysplastic Syndromes - epidemiology</topic><topic>Myelodysplastic Syndromes - therapy</topic><topic>tacrolimus</topic><topic>Tacrolimus - administration &amp; dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hayashi, Kiyohito</creatorcontrib><creatorcontrib>Tasaka, Taizo</creatorcontrib><creatorcontrib>Hirose, Tadashi</creatorcontrib><creatorcontrib>Furukawa, Satoko</creatorcontrib><creatorcontrib>Kohguchi, Katsunori</creatorcontrib><creatorcontrib>Matsuhashi, Yoshiko</creatorcontrib><creatorcontrib>Wada, Hideho</creatorcontrib><creatorcontrib>Tohyama, Kaoru</creatorcontrib><creatorcontrib>Sugihara, Takashi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Internal Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hayashi, Kiyohito</au><au>Tasaka, Taizo</au><au>Hirose, Tadashi</au><au>Furukawa, Satoko</au><au>Kohguchi, Katsunori</au><au>Matsuhashi, Yoshiko</au><au>Wada, Hideho</au><au>Tohyama, Kaoru</au><au>Sugihara, Takashi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Delayed False Elevation of Circulating Tacrolimus Concentrations after Cord Blood Transplantation in a Patient with Myelodysplastic Syndrome</atitle><jtitle>Internal Medicine</jtitle><addtitle>Intern. Med.</addtitle><date>2014-01-01</date><risdate>2014</risdate><volume>53</volume><issue>22</issue><spage>2635</spage><epage>2638</epage><pages>2635-2638</pages><issn>0918-2918</issn><eissn>1349-7235</eissn><abstract>We herein describe the case of a 60-year-old man with a history of Behçet's disease and myelodysplastic syndrome who received cord blood transplantation (CBT). The patient was given anti-thymocyte globulin conditioning and tacrolimus to prevent graft-versus-host disease. Two months after CBT, his blood Tac concentration measured by an antibody-conjugated magnetic immunoassay (ACMIA) was found to have increased &gt;4-fold, even after the Tac treatment was stopped. This false response was caused by the interference of endogenous heterophilic antibodies with ACMIA. Therefore, physicians must be aware of possible false ACMIA results for patients with a history of autoimmune disease and/or treated by xenogeneic antibody therapy.</abstract><cop>Japan</cop><pub>The Japanese Society of Internal Medicine</pub><pmid>25400189</pmid><doi>10.2169/internalmedicine.53.2170</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-2918
ispartof Internal Medicine, 2014, Vol.53(22), pp.2635-2638
issn 0918-2918
1349-7235
language eng
recordid cdi_proquest_miscellaneous_1794501347
source MEDLINE; J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese
subjects antibody-conjugated magnetic immunoassay
autoimmune diseases
Behcet Syndrome - epidemiology
Cord Blood Stem Cell Transplantation
cord blood transplantation
Cyclosporine - administration & dosage
False Positive Reactions
Graft vs Host Disease - prevention & control
Humans
Immunoassay
Immunosuppressive Agents - administration & dosage
Male
Middle Aged
Myelodysplastic Syndromes - epidemiology
Myelodysplastic Syndromes - therapy
tacrolimus
Tacrolimus - administration & dosage
title Delayed False Elevation of Circulating Tacrolimus Concentrations after Cord Blood Transplantation in a Patient with Myelodysplastic Syndrome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T01%3A04%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Delayed%20False%20Elevation%20of%20Circulating%20Tacrolimus%20Concentrations%20after%20Cord%20Blood%20Transplantation%20in%20a%20Patient%20with%20Myelodysplastic%20Syndrome&rft.jtitle=Internal%20Medicine&rft.au=Hayashi,%20Kiyohito&rft.date=2014-01-01&rft.volume=53&rft.issue=22&rft.spage=2635&rft.epage=2638&rft.pages=2635-2638&rft.issn=0918-2918&rft.eissn=1349-7235&rft_id=info:doi/10.2169/internalmedicine.53.2170&rft_dat=%3Cproquest_cross%3E1794501347%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1634498036&rft_id=info:pmid/25400189&rfr_iscdi=true